Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Controversies in Nephrology
You have accessRestricted Access

Protocol Transplant Biopsies in Kidney Allografts: Why and When Are They Indicated?

Lorraine C. Racusen
CJASN January 2006, 1 (1) 144-147; DOI: https://doi.org/10.2215/CJN.01010905
Lorraine C. Racusen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Recommendations for protocol biopsiesa

    RecommendationAllograft Patient Population
    Standard practice
        postimplantationAll recipients
        weeklyAll recipients with persistent DGF
        within 3 moAll highly sensitized/at-risk patients (unless clinical rejection has occurred)
        at time of detectionAny recipient with significantly increased urine or plasma markers of PPV
    Strongly recommended
        6 to 12 moRecipients with high CNI exposure, H/O toxicity
        6 to 12 moRecipients with H/O prolonged DGF, rejection
    Recommended for study (with interventional trials)
        1 to 3 moAll recipients
        6 to 12 moAll recipients
    • ↵ a DGF, delayed graft function; PPV, polyoma virus, CNI, calcineurin inhibitor; H/O, history of.

PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology
Vol. 1, Issue 1
January 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Protocol Transplant Biopsies in Kidney Allografts: Why and When Are They Indicated?
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Protocol Transplant Biopsies in Kidney Allografts: Why and When Are They Indicated?
Lorraine C. Racusen
CJASN Jan 2006, 1 (1) 144-147; DOI: 10.2215/CJN.01010905

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Protocol Transplant Biopsies in Kidney Allografts: Why and When Are They Indicated?
Lorraine C. Racusen
CJASN Jan 2006, 1 (1) 144-147; DOI: 10.2215/CJN.01010905
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
  • Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
  • Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con
Show more Controversies in Nephrology

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire